<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38690504</PMID><DateRevised><Year>2024</Year><Month>05</Month><Day>02</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Sinus Tachycardia Following COVID-19 and Its Implications.</ArticleTitle><Pagination><StartPage>e57320</StartPage><MedlinePgn>e57320</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e57320</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.57320</ELocationID><Abstract><AbstractText>Background Within the cardiovascular system, sinus tachycardia has been a noted finding in patients with post-COVID-19 syndrome (symptoms persisting beyond 12 weeks post-infection). To better understand post-COVID-19 tachycardia, we examined the prevalence of sinus tachycardia 12-16 weeks after diagnosis of SARS-COV-2 infection and its correlation with intensive care utilization, ventilator use, and mortality in vaccinated and unvaccinated patients. Methods We identified adult patients in the TriNetX COVID-19 Research Network with confirmed SARS-COV-2 diagnosis from January 20th, 2020, to February 14th, 2022, and sinus tachycardia 12-16 weeks after diagnosis. Two cohorts were created: patients who developed tachycardia 12 weeks after initial diagnosis and patients without tachycardia. The tachycardia cohort was divided further based on vaccination status. Results Of 1,363,907 patients included, 30,705 (2.2%) developed tachycardia. The patients with tachycardia had more comorbidities. Using propensity score matching (PSM), two cohorts of 30,702 were created. The SARS-COV-2 tachycardic cohort had higher mortality (5.1% vs 2.1%, p&lt;0.001), critical care utilization (5.8% vs 2.2%, p&lt;0.001), and ventilator use (1.8% vs 0.5%, p&lt;0.001). Out of 22,878 patients with persistent tachycardia and recorded vaccination status, 14,840 (65%) were not vaccinated. Mortality (5.9% vs 2.3%, p&lt;0.001), critical care utilization (8.3% vs 3.6%, p&lt;0.001), and ventilator use (3.8% vs 0.6%, p&lt;0.001) were higher in the non-vaccinated patients&#xa0;compared with the vaccinated patients after PSM.&#xa0; Conclusion The prevalence of persistent tachycardia after SARS-COV-2 infection is notable at 2.2%. Patients with persistent tachycardia have higher mortality rates and demonstrate greater healthcare utilization at one year compared to patients without persistent tachycardia, particularly if unvaccinated.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024, Amir-Kabirian et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Amir-Kabirian</LastName><ForeName>Borna</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Internal Medicine, CAMC Institute for Academic Medicine, Charleston, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Annie</LastName><ForeName>Frank H</ForeName><Initials>FH</Initials><AffiliationInfo><Affiliation>Cardiology, CAMC Institute for Academic Medicine, Charleston, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koontz</LastName><ForeName>Morgan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Critical Care Medicine, CAMC Institute for Academic Medicine, Charleston, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ihle</LastName><ForeName>Rayan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Critical Care Medicine, CAMC Institute for Academic Medicine, Charleston, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">covid-19</Keyword><Keyword MajorTopicYN="N">long covid</Keyword><Keyword MajorTopicYN="N">sars-cov-2</Keyword><Keyword MajorTopicYN="N">sinus tachycardia</Keyword><Keyword MajorTopicYN="N">vaccination</Keyword></KeywordList><CoiStatement>The authors have declared financial relationships, which are detailed in the next section.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>1</Day><Hour>3</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38690504</ArticleId><ArticleId IdType="pmc">PMC11060114</ArticleId><ArticleId IdType="doi">10.7759/cureus.57320</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mathieu E, Ritchie H, Rod&#xe9;s-Guirao Rod&#xe9;s-Guirao, et al.  Coronavirus Pandemic (COVID-19)  [
Mar;
2024 
]. 2020. http://OurWorldInData.org. https://ourworldindata.org/coronavirus http://OurWorldInData.org. https://ourworldindata.org/coronavirus</Citation></Reference><Reference><Citation>Post-acute COVID-19 syndrome. Nalbandian A, Sehgal K, Gupta A, et al. Nat Med. 2021;27:601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Post-Covid syndrome: incidence, clinical spectrum, and challenges for primary healthcare professionals. Pavli A, Theodoridou M, Maltezou HC. Arch Med Res. 2021;52:575&#x2013;581.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8093949</ArticleId><ArticleId IdType="pubmed">33962805</ArticleId></ArticleIdList></Reference><Reference><Citation>Inappropriate sinus tachycardia in post-COVID-19 syndrome. Arany&#xf3; J, Bazan V, Llad&#xf3;s G, et al. Sci Rep. 2022;12:298.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8741896</ArticleId><ArticleId IdType="pubmed">34996973</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardioimmunology of arrhythmias: the role of autoimmune&#xa0;and inflammatory cardiac&#xa0;channelopathies. Lazzerini PE, Laghi-Pasini F, Boutjdir M, Capecchi PL. Nat Rev Immunol. 2019;19:63&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">30552387</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review. Zubair AS, McAlpine LS, Gardin T, Farhadian S, Kuruvilla DE, Spudich S. JAMA Neurol. 2020;77:1018&#x2013;1027.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7484225</ArticleId><ArticleId IdType="pubmed">32469387</ArticleId></ArticleIdList></Reference><Reference><Citation>Six-month sequelae of post-vaccination SARS-CoV-2 infection: a retrospective cohort study of 10,024 breakthrough infections. Taquet M, Dercon Q, Harrison PJ. Brain Behav Immun. 2022;103:154&#x2013;162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9013695</ArticleId><ArticleId IdType="pubmed">35447302</ArticleId></ArticleIdList></Reference><Reference><Citation>Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis. Zheng C, Shao W, Chen X, Zhang B, Wang G, Zhang W. Int J Infect Dis. 2022;114:252&#x2013;260.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8595975</ArticleId><ArticleId IdType="pubmed">34800687</ArticleId></ArticleIdList></Reference><Reference><Citation>Management of arrhythmias associated with COVID-19. Desai AD, Boursiquot BC, Melki L, Wan EY. Curr Cardiol Rep. 2020;23:2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7685181</ArticleId><ArticleId IdType="pubmed">33231782</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardiovascular complications of severe acute respiratory syndrome. Yu CM, Wong RS, Wu EB, et al. Postgrad Med J. 2006;82:140&#x2013;144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2596695</ArticleId><ArticleId IdType="pubmed">16461478</ArticleId></ArticleIdList></Reference><Reference><Citation>The relationship of COVID-19 vaccination with mortality among 86,732 hospitalized patients: subpopulations, patient factors, and changes over time. Baker TB, Bolt DM, Smith SS, et al. J Gen Intern Med. 2023;38:1248&#x2013;1255.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9848037</ArticleId><ArticleId IdType="pubmed">36652098</ArticleId></ArticleIdList></Reference><Reference><Citation>Association of COVID-19 vaccinations with intensive care unit admissions and outcome of critically ill patients with COVID-19 pneumonia in Lombardy, Italy. Grasselli G, Zanella A, Carlesso E, et al. JAMA Netw Open. 2022;5:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9614574</ArticleId><ArticleId IdType="pubmed">36301541</ArticleId></ArticleIdList></Reference><Reference><Citation>Inappropriate sinus tachycardia: etiology, pathophysiology, and management: JACC review topic of the week. Ahmed A, Pothineni NV, Charate R, et al. J Am Coll Cardiol. 2022;79:2450&#x2013;2462.</Citation><ArticleIdList><ArticleId IdType="pubmed">35710196</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2018;Ivabradin&#x2019; versus &#x2018;Carvedilol&#x2019; in the management of Post-COVID-19 palpitation with sinus tachycardia. Jadhav K, Jariwala P. Indian Heart J. 2020;72:0.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>